TNF-TNFR2 Signaling Inhibits Th2 and Th17 Polarization and Alleviates Allergic Airway Inflammation

16Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: TNF-TNFR2 signaling has been indicated to be involved in CD4+ T lymphocyte differentiation. However, its role in allergic airway inflammation is not well understood. Objectives: The aim of this study was to investigate the role of TNF-TNFR2 signaling in allergic airway inflammation. Methods and Results: In this study, we used an allergen-induced asthma model to show that TNF-TNFR2 signaling alleviated allergic airway inflammation by reducing the airway infiltration of eosinophils and neutrophils. Activated TNF-TNFR2 signaling decreased the expression of Th2 and Th17 cytokines in serum and bronchoalveolar lavage fluid. Furthermore, TNF-TNFR2 signaling inhibited Th2 and Th17 polarization but promoted Th1 and CD4+CD25+ T cell differentiation in vivo. Conclusions: Our study indicates that TNF-TNFR2 signaling alleviates allergic airway inflammation through inhibition of Th2 and Th17 cell differentiation.

Cite

CITATION STYLE

APA

Peng, J., Li, X. M., Zhang, G. R., Cheng, Y., Chen, X., Gu, W., & Guo, X. J. (2019). TNF-TNFR2 Signaling Inhibits Th2 and Th17 Polarization and Alleviates Allergic Airway Inflammation. International Archives of Allergy and Immunology, 178(3), 281–290. https://doi.org/10.1159/000493583

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free